Skip to main content
Premium Trial:

Request an Annual Quote

Wako to be Biocius' Japan Distributor

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Biocius Life Sciences said that it has signed up Wako Pure Chemical Industries to distribute its mass spectrometry systems and services in Japan, under an agreement announced today.

Osaka-based Wako will be the exclusive distributor in Japan for the Biocius RapidFire label-free high-throughput systems and for the firm's portfolio of contract research offerings and services, including in vitro ADME screening applications, such as the recently launched RF300 system, Biocius said.

Wako's BioMedical Systems Department GM Haruki Oishi said in a statement that Biocius' tools and services "will enable us to provide our customers with drug discovery solutions" and with "a means to investigate therapeutics that have been difficult to analyze by conventional methods."

Wako will support the Biocius technology in Japan with application scientists and field support engineers.

Biocius was spun out of BioTrove late last year, following that firm's acquisition by Life Technologies.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.